Major controversy exists about whether to treat patients with ST-segment elevation myocardial infarction using fibrinolysis or percutaneous intervention. A study of 1,492 patients from approximately 60% of French hospitals demonstrates that similarly excellent 5-year outcomes can be achieved with either reperfusion strategy. Therefore, one size need not necessarily fit all.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Danchin, N. et al. Five-year survival in patients with ST-segment elevation myocardial infarction according to modalities of reperfusion therapy: the French Registry on Acute ST-Elevation and Non-ST-Elevation Myocardial Infarction (FAST-MI) 2005 cohort. Circulation 129, 1629–1636 (2014).
Armstrong, P. W. et al. Fibrinolysis or primary PCI in ST-segment elevation myocardial infarction. N. Engl. J. Med. 368, 1379–1387 (2013).
Roe, M. T. et al. Treatments, trends, and outcomes of acute myocardial infarction and percutaneous coronary intervention. J. Am. Coll. Cardiol. 56, 254–263 (2010).
Terkelsen, C. J. et al. System delay and mortality among patients with STEMI treated with primary percutaneous coronary intervention. JAMA 304, 763–771 (2010).
Lambert, L. et al. Association between timeliness of reperfusion therapy and clinical outcomes in ST-elevation myocardial infarction. JAMA 303, 2148–2155 (2010).
Concannon, T. W., Nelson, J., Kent, D. M. & Griffith, J. L. Evidence of systematic duplication by new percutaneous coronary intervention programs. Circ. Cardiovasc. Qual. Outcomes 6, 400–408 (2013).
McGrath, P. D. et al. Relation between operator and hospital volume and outcomes following percutaneous coronary interventions in the era of the coronary stent. JAMA 284, 3139–3144 (2000).
Armstrong, P. W. & Boden, W. E. Reperfusion paradox in ST-segment elevation myocardial infarction. Ann. Intern. Med. 155, 389–391 (2011).
O'Gara, P. T. et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction. J. Am. Coll. Cardiol. 61, e87–e140 (2013).
Huber, K., Gersh, B. J., Goldstein, P., Granger, C. B. & Armstrong, P. W. The organization, function, and outcomes of ST-elevation myocardial infarction networks worldwide: current state, unmet needs and future directions. Eur. Heart J. http://dx.doi.org/10.1093/eurheartj/ehu125.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares that he is a consultant for, and has received research grants for the STREAM trial and honoraria from, Boehringer Ingelheim.
Rights and permissions
About this article
Cite this article
Armstrong, P. Right direction—moving proximally in timing of STEMI care. Nat Rev Cardiol 11, 320–321 (2014). https://doi.org/10.1038/nrcardio.2014.61
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrcardio.2014.61